GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $3.63B (100.0% shares, 0.0% debt)

Holdings (15)

DLO DLOCAL 20.0%

Value $725M Shares 63,906,695 Share Price $11.34 Est. Cost/Share — Unrealized @ Report Date —

CHYM CHIME 18.3%

Value $663M Shares 19,208,760 Share Price $34.51 Est. Cost/Share — Unrealized @ Report Date —

ALHC ALIGNMENT HEALTHCARE 17.0%

Value $616M Shares 43,993,323 Share Price $14.00 Est. Cost/Share — Unrealized @ Report Date —

XP XP, INC 14.2%

Value $515M Shares 25,517,733 Share Price $20.20 Est. Cost/Share — Unrealized @ Report Date —

— AKERO THERAPEUTICS 8.4%

Value $306M Shares 5,733,989 Share Price $53.36 Est. Cost/Share — Unrealized @ Report Date —

ALKT ALKAMI 8.0%

Value $291M Shares 9,645,318 Share Price $30.14 Est. Cost/Share — Unrealized @ Report Date —

PHVS PHARVARIS 3.7%

Value $133M Shares 7,531,252 Share Price $17.60 Est. Cost/Share — Unrealized @ Report Date —

CNTA CENTESSA PHARMACEUTICALS 3.5%

Value $127M Shares 9,681,818 Share Price $13.14 Est. Cost/Share — Unrealized @ Report Date —

BULL WEBULL 2.4%

Value $85.49M Shares 7,148,051 Share Price $11.96 Est. Cost/Share — Unrealized @ Report Date —

EWCZ EUROPEAN WAX CENTER 2.0%

Value $73.81M Shares 13,110,492 Share Price $5.63 Est. Cost/Share — Unrealized @ Report Date —

RPRX ROYALTY PHARMA 1.5%

Value $54.05M Shares 1,500,000 Share Price $36.03 Est. Cost/Share — Unrealized @ Report Date —

RSKD RISKIFIED 0.7%

Value $26.57M Shares 5,324,998 Share Price $4.99 Est. Cost/Share — Unrealized @ Report Date —

ADAG ADAGENE 0.2%

Value $7.461M Shares 3,825,952 Share Price $1.95 Est. Cost/Share — Unrealized @ Report Date —

ALMS ALUMIS 0.1%

Value $3.893M Shares 1,297,530 Share Price $3.00 Est. Cost/Share — Unrealized @ Report Date —

GROV GROVE COLLABORATIVE 0.1%

Value $2.846M Shares 2,474,859 Share Price $1.15 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
DLO	DLOCAL	63,906,695	$725M	20.0%	$11.34	—	—	CL A	G29018101
CHYM	CHIME	19,208,760	$663M	18.3%	$34.51	—	—	COM SHS CL A	16935C109
ALHC	ALIGNMENT HEALTHCARE	43,993,323	$616M	17.0%	$14.00	—	—	COM	01625V104
XP	XP, INC	25,517,733	$515M	14.2%	$20.20	—	—	CL A	G98239109
—	AKERO THERAPEUTICS	5,733,989	$306M	8.4%	$53.36	—	—	COM	00973Y108
ALKT	ALKAMI	9,645,318	$291M	8.0%	$30.14	—	—	COM	01644J108
PHVS	PHARVARIS	7,531,252	$133M	3.7%	$17.60	—	—	COM	N69605108
CNTA	CENTESSA PHARMACEUTICALS	9,681,818	$127M	3.5%	$13.14	—	—	ADS	152309100
BULL	WEBULL	7,148,051	$85.49M	2.4%	$11.96	—	—	ORD SHS	G9572D103
EWCZ	EUROPEAN WAX CENTER	13,110,492	$73.81M	2.0%	$5.63	—	—	CL A	29882P106
RPRX	ROYALTY PHARMA	1,500,000	$54.05M	1.5%	$36.03	—	—	CL A	G7709Q104
RSKD	RISKIFIED	5,324,998	$26.57M	0.7%	$4.99	—	—	CL A	M8216R109
ADAG	ADAGENE	3,825,952	$7.461M	0.2%	$1.95	—	—	ADS	005329107
ALMS	ALUMIS	1,297,530	$3.893M	0.1%	$3.00	—	—	COM	022307102
GROV	GROVE COLLABORATIVE	2,474,859	$2.846M	0.1%	$1.15	—	—	CL A	39957D201